Kidney Failure, Chronic
265
13
19
165
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
56 trials with published results (21%)
Research Maturity
165 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
9.1%
24 terminated out of 265 trials
87.3%
+0.8% vs benchmark
24%
64 trials in Phase 3/4
34%
56 of 165 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 165 completed trials
Clinical Trials (265)
Probiotic and Synbiotic Supplements in Hemodialysis Patients
Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients
Shingrix in Renal Transplant Recipients
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Physical Exercise and Biomolecular Analysis to Reduce Uremic Toxins in Chronic Kidney Disease: An Exploratory Study
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
Search for New Methods to Detect Acute Renal Failure
Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
Prediction of Chronic Allograft Nephropathy
A Communication Tool to Assist Older Adults Facing Dialysis Choices
Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications
Prevention of Peritonitis in Peritoneal Dialysis
A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)
A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis
A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011)
Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
DIALysis With EXpanded Solute Removal
French AKI Registry (FAKIR): A Multicenter Study on the In-Hospital Management and Outcomes of Severe Acute Kidney Injury in Nephrology Units
Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis